Last reviewed · How we verify
NCT05011136
Physician Reimbursement Home Patients
trial testing No intervention. This is a qualitative study in ESRD in 68 participants. Completed in 31 December 2021.
31 December 2021
Quick facts
| Lead sponsor | Satellite Healthcare |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 68 |
| Start date | 1 September 2021 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- No intervention. This is a qualitative study
Conditions studied
- ESRD — all drugs for ESRD →
Sponsor
Satellite Healthcare — full company profile →
Who can join
18 and older, any sex, with ESRD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational study using an online survey to solicit information from nephrologists who care for dialysis patients about the time and effort involved in providing care to home dialysis patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05011136
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ESRD
Currently open trials in the same condition.
- NCT06913647 — Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis · Phase 2 · recruiting
- NCT06366230 — Adding Urea to the Final Dialysis Fluid · Phase 1, PHASE2 · recruiting
- NCT05339139 — SAfety of Regional Citrate Anticoagulation (SARCA Study) · Phase 3 · recruiting
- NCT05434325 — TESTING -ON Post-Trial ObservatioNal Cohort Study · recruiting
- NCT05309785 — Safety and Efficacy of Canagliflozin in Advanced CKD · Phase 4 · active not recruiting
Other Satellite Healthcare trials
Trials by the same sponsor.
- NCT05400720 — Peer Support In Dialysis · NA · completed
- NCT05022225 — Psychosocial Reasons for Transfer to In Center Hemodialysis in Home Dialysis Patients- A Focus Group Study · completed
- NCT04988568 — Experience of Patients Starting Hemodialysis · completed
- NCT04806126 — Evaluation of a Virtual Home Dialysis Mentoring Program (Home) · completed
- NCT04666844 — Predicting Transfers to Hemodialysis in Peritoneal Dialysis Patients Using the Surprise Question · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05011136 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Satellite Healthcare
- Last refreshed: 11 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05011136.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing